164 related articles for article (PubMed ID: 35842534)
21. Use of Memorial Sloan Kettering Cancer Center nomogram to guide intraoperative sentinel lymph node frozen sections in patients with early breast cancer.
Houpu Y; Fei X; Yang Y; Fuzhong T; Peng L; Bo Z; Lin C; Yingming C; Miao L; Hongjun L; Siyuan W; Yuan P; Danhua S; Shu W
J Surg Oncol; 2019 Sep; 120(4):587-592. PubMed ID: 31309573
[TBL] [Abstract][Full Text] [Related]
22. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of three models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a retrospective study of 77 patients].
Terrier C; Tariel O; Coutant C; De Saint Hilaire P; Devouassoux M; Rudigoz RC; Dubernard G
J Gynecol Obstet Biol Reprod (Paris); 2012 May; 41(3):227-34. PubMed ID: 22464015
[TBL] [Abstract][Full Text] [Related]
24. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
[TBL] [Abstract][Full Text] [Related]
25. High intersystem variability for the prediction of additional axillary non-sentinel lymph node involvement in individual patients with sentinel node-positive breast cancer.
van den Hoven I; Kuijt GP; Voogd AC; Roumen RM
Ann Surg Oncol; 2012 Jun; 19(6):1841-9. PubMed ID: 22207045
[TBL] [Abstract][Full Text] [Related]
26. Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers.
Bonsang-Kitzis H; Mouttet-Boizat D; Guillot E; Feron JG; Fourchotte V; Alran S; Pierga JY; Cottu P; Lerebours F; Stevens D; Vincent-Salomon A; Sigal-Zafrani B; Campana F; Rouzier R; Reyal F
PLoS One; 2017; 12(2):e0169962. PubMed ID: 28241044
[TBL] [Abstract][Full Text] [Related]
27. Non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node: validation of five nomograms and development of a new predictive model.
Lombardi A; Maggi S; Lo Russo M; Scopinaro F; Di Stefano D; Pittau MG; Tiberi S; Amanti C
Tumori; 2011; 97(6):749-55. PubMed ID: 22322842
[TBL] [Abstract][Full Text] [Related]
28. Applicability of two different validated models to predict axillary non-sentinel lymph node status by sentinel node biopsy in a single Italian center.
Bertozzi S; Londero AP; Giacomuzzi F; Angione V; Carbone A; Petri R; Bernardi S
Breast Cancer; 2015 Jul; 22(4):350-5. PubMed ID: 23832256
[TBL] [Abstract][Full Text] [Related]
29. Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer.
Moghaddam Y; Falzon M; Fulford L; Williams NR; Keshtgar MR
Br J Surg; 2010 Nov; 97(11):1646-52. PubMed ID: 20641049
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.
D'Eredità G; Troilo VL; Giardina C; Napoli A; Rubini G; Fischetti F; Berardi T
Clin Breast Cancer; 2010 Dec; 10(6):445-51. PubMed ID: 21147687
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2009 Jul; 16(7):1946-51. PubMed ID: 19408057
[TBL] [Abstract][Full Text] [Related]
32. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
[TBL] [Abstract][Full Text] [Related]
33. Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram.
Chue KM; Yong WS; Thike AA; Ahmed SS; Li HH; Wong CY; Ho GH; Madhukumar P; Tan BK; Ong KW; Tan PH
J Clin Pathol; 2014 Feb; 67(2):112-9. PubMed ID: 24048026
[TBL] [Abstract][Full Text] [Related]
34. Novel factors to improve prediction of nodal positivity in patients with clinical T1/T2 breast cancers.
Torstenson T; Shah-Khan MG; Hoskin TL; Morton MJ; Adamczyk DL; Jones KN; Case J; Chartier S; Boughey JC
Ann Surg Oncol; 2013 Oct; 20(10):3286-93. PubMed ID: 23846779
[TBL] [Abstract][Full Text] [Related]
35. Integrative 3' Untranslated Region-Based Model to Identify Patients with Low Risk of Axillary Lymph Node Metastasis in Operable Triple-Negative Breast Cancer.
Wang L; Hu X; Wang P; Shao ZM
Oncologist; 2019 Jan; 24(1):22-30. PubMed ID: 30082491
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of nomograms for predicting axillary non-SLN metastases in breast cancer patients with 1-2 positive sentinel lymph node macro-metastases: a retrospective analysis of two independent cohorts.
Yu Y; Wang Z; Wei Z; Yu B; Shen P; Yan Y; You W
BMC Cancer; 2021 Apr; 21(1):466. PubMed ID: 33902502
[TBL] [Abstract][Full Text] [Related]
37. Axillary lymph node dissection in the case of sentinel lymph node micrometastatic invasion: evaluation of three predictive models.
Orsoni M; Clerc J; Golfier F; Cortet M; Raudrant D; Krauth JS
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):334-7. PubMed ID: 21669485
[TBL] [Abstract][Full Text] [Related]
38. Nomograms for preoperative prediction of axillary nodal status in breast cancer.
Dihge L; Bendahl PO; Rydén L
Br J Surg; 2017 Oct; 104(11):1494-1505. PubMed ID: 28718896
[TBL] [Abstract][Full Text] [Related]
39. A breast cancer nomogram for prediction of non-sentinel node metastasis - validation of fourteen existing models.
Koca B; Kuru B; Ozen N; Yoruker S; Bek Y
Asian Pac J Cancer Prev; 2014; 15(3):1481-8. PubMed ID: 24606487
[TBL] [Abstract][Full Text] [Related]
40. Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes.
Yang Z; Lan X; Huang Z; Yang Y; Tang Y; Jing H; Wang J; Zhang J; Wang X; Gao J; Wang J; Xuan L; Fang Y; Ying J; Li Y; Huang X; Wang S
Breast; 2020 Oct; 53():143-151. PubMed ID: 32823167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
